Combination Rx Therapy Stalled Metastatic Breast Cancer
A medication that treats a type of leukemia targets a protein that’s involved in the spread of breast cancer. Combining this medication with a standard breast cancer therapy helped some patients live longer.
Updating Info on CML Rx
Chronic myeloid leukemia (CML) was once a dire diagnosis. Now the disease can be treated successfully in most people. The disease has to be treated over many years to be kept under control.
Attacking Leukemia Resistance
Chronic myeloid leukemia ( CML ) is a tricky cancer because it can respond well to initial therapy, but then that drug sometimes stops working. The same thing can happen when different – second-line – drugs are used. The reason for this is that the disease tends to keep changing or mutating.
Living With a Once Deadly Leukemia
Chronic myeloid leukemia – CML – is a relatively rare blood cancer that’s diagnosed in about 5,000 Americans every year. It used to be a dire diagnosis with a poor outlook. Not anymore, though.
New Chronic Myeloid Leukemia Drug
Chronic myeloid leukemia often responds to first-line treatment. Gleevec ( imatinib ) is the standard first-line medication. The disease usually quiets for a time, then comes back. A new drug has been approved to treat this blood and bone marrow cancer.
Young People with Chronic Myeloid Leukemia
Since targeted therapies known as tyrosine kinase inhibitors (TKI) have been in use, the outlook for people diagnosed with chronic myeloid leukemia has improved dramatically. Unfortunately, this trend isn't true for all patients.
With CML, Third Time Can Be a Charm
The course of chronic myeloid leukemia (CML) has changed substantially thanks to the use of a class of drugs called tyrosine kinase inhibitors (TKIs). How these drugs are being used is changing too.
Outwitting Chronic Myeloid Leukemia
About 20 percent of all leukemias in the Western world are chronic myeloid leukemia ( CML ). Today's treatments target an abnormal chromosome that causes the disease, but new theories about how to outwit this resilient disease are sprouting.
Extending Lives of Men With Prostate Cancer
Usually, drug companies are the organizations that discover new medicines. It's rare for drugs to come out of academic labs, but that's just what happened with the first medication found to be effective against advanced prostate cancer.
Tasigna Recommended for Second-Line CML
Tasigna ( nilotinib ) is one of the three major medications currently being used to treat chronic myeloid leukemia ( CML ). Now it has become a preferred drug in one country.